ZYME
Overvalued by 216.3% based on the discounted cash flow analysis.
Market cap | $901.72 Million |
---|---|
Enterprise Value | $881.09 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $-1.62 |
Beta | 1.17 |
Outstanding Shares | 75,846,681 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -8.01 |
---|---|
PEG | -0.01 |
Price to Sales | - |
Price to Book Ratio | 2.83 |
Enterprise Value to Revenue | 20.51 |
Enterprise Value to EBIT | -0.01 |
Enterprise Value to Net Income | -1 |
Total Debt to Enterprise | 0.05 |
Debt to Equity | 0.13 |
No data
No data